C. Gamonet

发表

Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts

M. Deschamps, E. Deconinck, P. Tiberghien, 2016, Gene Therapy.

How to quantify microparticles in RBCs? A validated flow cytometry method allows the detection of an increase in microparticles during storage

P. Morel, F. Garnache-Ottou, P. Tiberghien, 2017, Transfusion.

Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10

J. Renauld, M. Mohty, P. Saas, 2015, Mucosal Immunology.

Processing methods and storage duration impact extracellular vesicle counts in red blood cell units.

P. Morel, F. Garnache-Ottou, P. Tiberghien, 2020, Blood advances.

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes

P. Rohrlich, M. Deschamps, C. Borg, 2015, International journal of cancer.

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

E. Tartour, X. Pivot, J. Pallandre, 2016, Cancer research.

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

F. Aubin, F. Garnache-Ottou, M. Deschamps, 2016, Experimental Hematology & Oncology.

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

F. Aubin, F. Garnache-Ottou, M. Deschamps, 2015, Experimental Hematology & Oncology.

The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis.

M. Deschamps, C. Ferrand, I. Auger, 2015, Rheumatology.

Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus

F. Aubin, C. Ferrand, P. Musette, 2014, Experimental dermatology.

OP-BRHE150210 1..2

M. Deschamps, C. Ferrand, G. Herbein, 2015 .